Angus Angermeyer

Angus Angermeyer

orcid

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2015 in Cell Host & Microbe
Verified
Journal Article
Closed access
PJPeter Jorth
Peter Jorth
BSBenjamin J. Staudinger
Benjamin J. Staudinger
XWXia Wu
Xia Wu
KHKatherine B. Hisert
Katherine B. Hisert
HHHillary Hayden
Hillary Hayden
PSPradeep K. Singh
Pradeep K. Singh

30 July 2021 in Science
Verified
Journal Article
Closed access
PDF file
KLKristen N. LeGault
Kristen N. LeGault
SHStephanie G. Hays
Stephanie G. Hays
AAAngus Angermeyer
Angus Angermeyer
AMAmelia C. McKitterick
Amelia C. McKitterick
FJFatema-Tuz Johura
Fatema-Tuz Johura
KSKimberley Seed
Kimberley Seed
Back to the future phage: The interrelationships that prevail between bacteria and their phage parasites are subtle and evolutionarily dynamic. In Bangladesh, cholera remains endemic, and natural, clinically relevant infections have been monitored for decades. LeGault et al . investigated the relationship between antiphage defenses and phage counterresponses in human Vibrio cholerae cases. These bacteria have integrative and conjugative elements called SXT ICEs, which are notorious for carrying antibiotic resistance genes but also contain genes that defend bacteria from phage. Phage have their own counterdefense mechanisms. One constitutes a 44–amino acid peptide product in a phage lineage that inhibits the bacterium’s SXT ICE defenses. In a further complication, SXT-ICEs also inhibit the lysogenic phage that transmit Vibrio virulence factors, including cholera toxin. Therefore, this process drives bacterial diversity as well as antibiotic resistance. —CA

25 August 2009 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
PDF file
SLSamuel Lee
Samuel Lee
AHAaron Hinz
Aaron Hinz
EBElizabeth Bauerle
Elizabeth Bauerle
AAAngus Angermeyer
Angus Angermeyer
KJKaty Juhaszova
Katy Juhaszova
CMColin Manoil
Colin Manoil
This report describes the identification and analysis of a 2-component regulator of Pseudomonas aeruginosa that is a potential aminoglycoside antibiotic combination therapy target. The regulator, AmgRS, was identified in a screen of a comprehensive, defined transposon mutant library for functions whose inactivation increased tobramycin sensitivity. AmgRS mutations enhanced aminoglycoside action against bacteria grown planktonically and in antibiotic tolerant biofilms, against genetically resistant clinical isolates, and in lethal infections of mice. Drugs targeting AmgRS would thus be expected to enhance the clinical efficacy of aminoglycosides. Unexpectedly, the loss of AmgRS reduced virulence in the absence of antibiotics, indicating that its inactivation could protect against infection directly as well as by enhancing aminoglycoside action. Transcription profiling and phenotypic analysis suggested that AmgRS controls an adaptive response to membrane stress, which can be caused by aminoglycoside-induced translational misreading. These results help validate AmgRS as a potential antibiotic combination target for P. aeruginosa and indicate that fundamental stress responses may be a valuable general source of such targets.

1 April 2014 in American Journal of Respiratory and Critical Care Medicine
Verified
Journal Article
Closed access
BSBenjamin J. Staudinger
Benjamin J. Staudinger
JMJocelyn Fraga Muller
Jocelyn Fraga Muller
SHSkarphéðinn Halldórsson
Skarphéðinn Halldórsson
BBBlaise Boles
Blaise Boles
AAAngus Angermeyer
Angus Angermeyer
PSPradeep K. Singh
Pradeep K. Singh
Rationale: Progress has been made in understanding how the cystic fibrosis (CF) basic defect produces lung infection susceptibility. However, it remains unclear why CF exclusively leads to chronic infections that are noninvasive and highly resistant to eradication. Although biofilm formation has been suggested as a mechanism, recent work raises questions about the role of biofilms in CF. Objectives: To learn how airway conditions attributed to CF transmembrane regulator dysfunction could lead to chronic infection, and to determine if biofilm-inhibiting genetic adaptations that are common in CF isolates affect the capacity of Pseudomonas aeruginosa to develop chronic infection phenotypes. Methods: We studied P. aeruginosa isolates grown in agar and mucus gels containing sputum from patients with CF and measured their susceptibility to killing by antibiotics and host defenses. We also measured the invasive virulence of P. aeruginosa grown in sputum gels using airway epithelial cells and a murine infection model. Measurements and Main Results: We found that conditions likely to result from increased mucus density, hyperinflammation, and defective bacterial killing could all cause P. aeruginosa to grow in bacterial aggregates. Aggregated growth markedly increased the resistance of bacteria to killing by host defenses and antibiotics, and reduced their invasiveness. In addition, we found that biofilm-inhibiting mutations do not impede aggregate formation in gel growth environments. Conclusions: Our findings suggest that conditions associated with several CF pathogenesis hypotheses could cause the noninvasive and resistant infection phenotype, independently of the bacterial functions needed for biofilm formation.

17 August 2016 in Estuaries and Coasts
Verified
Journal Article
Closed access
PDF file
SCSarah C. Crosby
Sarah C. Crosby
AAAngus Angermeyer
Angus Angermeyer
JAJennifer M. Adler
Jennifer M. Adler
MBMark D. Bertness
Mark D. Bertness
LDLinda A. Deegan
Linda A. Deegan
HLHeather M. Leslie
Heather M. Leslie

25 March 2019 in Philosophical Transactions of the Royal Society B: Biological Sciences
Verified
Journal Article
Open access
AMAmelia C. McKitterick
Amelia C. McKitterick
KLKristen N. LeGault
Kristen N. LeGault
AAAngus Angermeyer
Angus Angermeyer
MAMunirul Alam
Munirul Alam
KSKimberley Seed
Kimberley Seed
CRISPR-Cas systems function as adaptive immune systems by acquiring nucleotide sequences called spacers that mediate sequence-specific defence against competitors. Uniquely, the phage ICP1 encodes a Type I-F CRISPR-Cas system that is deployed to target and overcome PLE, a mobile genetic element with anti-phage activity in Vibrio cholerae . Here, we exploit the arms race between ICP1 and PLE to examine spacer acquisition and interference under laboratory conditions to reconcile findings from wild populations. Natural ICP1 isolates encode multiple spacers directed against PLE, but we find that single spacers do not interfere equally with PLE mobilization. High-throughput sequencing to assay spacer acquisition reveals that ICP1 can also acquire spacers that target the V. cholerae chromosome. We find that targeting the V. cholerae chromosome proximal to PLE is sufficient to block PLE and is dependent on Cas2-3 helicase activity. We propose a model in which indirect chromosomal spacers are able to circumvent PLE by Cas2-3-mediated processive degradation of the V. cholerae chromosome before PLE mobilization. Generally, laboratory-acquired spacers are much more diverse than the subset of spacers maintained by ICP1 in nature, showing how evolutionary pressures can constrain CRISPR-Cas targeting in ways that are often not appreciated through in vitro analyses. This article is part of a discussion meeting issue ‘The ecology and evolution of prokaryotic CRISPR-Cas adaptive immune systems’.